| Breakdown | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 151.07B | 142.91B | 132.58B | 123.70B | 156.57B |
| Gross Profit | 51.60B | 66.31B | 60.54B | 55.35B | 66.27B |
| EBITDA | 50.43B | 70.71B | -1.46B | 32.41B | 27.55B |
| Net Income | 20.66B | 43.32B | -27.81B | 20.89B | 15.64B |
Balance Sheet | |||||
| Total Assets | 324.29B | 303.18B | 290.17B | 322.69B | 301.60B |
| Cash, Cash Equivalents and Short-Term Investments | 63.40B | 66.23B | 49.48B | 51.69B | 50.20B |
| Total Debt | 82.77B | 87.93B | 110.63B | 103.86B | 149.09B |
| Total Liabilities | 237.70B | 232.66B | 249.81B | 252.87B | 246.45B |
| Stockholders Equity | 84.57B | 68.20B | 38.62B | 68.61B | 54.48B |
Cash Flow | |||||
| Free Cash Flow | 17.79B | 21.88B | 16.34B | 3.38B | 14.80B |
| Operating Cash Flow | 22.54B | 25.95B | 18.67B | 5.39B | 17.99B |
| Investing Cash Flow | -8.87B | 30.00B | -5.80B | 10.02B | -4.95B |
| Financing Cash Flow | -14.95B | -41.28B | -7.79B | -16.97B | -19.07B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | ¥305.16B | 13.79 | 30.73% | 2.20% | 5.71% | -51.99% | |
71 Outperform | ¥83.17B | 14.29 | 11.16% | 3.41% | 11.29% | 22.71% | |
70 Outperform | ¥16.95B | 16.51 | ― | 1.49% | 0.06% | 5.50% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | ¥34.19B | 18.14 | ― | 2.59% | 0.68% | 33.74% | |
60 Neutral | ¥65.28B | 10.29 | ― | 2.18% | 6.54% | 140.15% | |
54 Neutral | ¥16.69B | 30.45 | ― | 1.13% | 3.36% | -15.06% |